CartiHeal Enrolls 200th Patient in Agili-C Study

CartiHeal enrolled the 200th patient in the Agili-C Investigational Device Exemption pivotal clinical study, up from 150 reported in 1Q19. The 200th patient was randomized to the Agili-C arm of the study and treated with three implants.

The goal of the study is to demonstrate superiority of the Agili-C implant vs. microfracture and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0